
From 2015 to 2019, switching commercially insured patients between infliximab products yielded no patient out-of-pocket savings and resulted in no savings to insurance payers after 2019.

From 2015 to 2019, switching commercially insured patients between infliximab products yielded no patient out-of-pocket savings and resulted in no savings to insurance payers after 2019.

Higher-performing Medicare accountable care organizations are smaller and characterized by real-time information sharing, regular performance feedback, primary care physician leaders, physician buy-in, and strong care management programs.

Following the Steward Health Care bankruptcy, Massachusetts law HB 5159 mandates rigorous oversight of for-profit health care transactions, providing a vital regulatory model for national replication.

This meta-analysis supports a role for oral nutrition supplements and/or intradialytic parenteral nutrition in improving nutrition status in hemodialysis patients.

Despite financial incentives for Medicare Advantage (MA) plans to reduce potentially inappropriate medication use post hospitalization, this study found that MA does not provide a clear advantage over traditional Medicare.

High-risk nonsteroidal anti-inflammatory drug use declined modestly in Virginia during the COVID-19 pandemic but remained prevalent from 2019 to 2021. Demographic disparities reveal distinct opportunities for targeted deprescribing interventions.

Constrained optimization empirically derived social risk weights that gave equal influence to subgroup performance by dual eligibility and disability in overall contract scores.

This study links county-level social vulnerability to variation in Medicare Advantage prior authorization policies.

Remote monitoring with tailored texts improved endocrine therapy adherence among breast cancer survivors with low symptom-management self-efficacy, with benefits becoming nonsignificant at higher self-efficacy levels.

Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence support.

Receipt of an insurer-provided grocery benefit was associated with decreased rates of diabetes with complications and increased medication adherence among a population with diabetes.

Analysis of billing codes before and after implementation of a care process for weight-focused visits revealed increased primary care revenue for these encounters.